George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThames V.2 Dp67 Regulatory News (D467)

Share Price Information for Thames V.2 Dp67 (D467)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.00
Bid: 9.00
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 10.00 (111.111%)
Open: 14.00
High: 14.00
Low: 14.00
Prev. Close: 14.00
D467 Live PriceLast checked at -
Downing FOUR VCT DP67 shares is an Investment Trust

To provide Shareholders with an attractive level of tax-free capital gains and income generated from a portfolio of investments in a range of different sectors.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Healthcare Prospectus

13 Oct 2022 17:35

Publication of Healthcare Prospectus

Thames Ventures VCT 2 plc (“the Company")

LEI: 21380035MV1VRYEXPR95

13 October 2022

Publication of Healthcare Prospectus

 

The Company has today issued a prospectus (comprising a Securities Note, Registration Document and Summary) (the "Healthcare Prospectus") relating to offers for subscription (“Offers”) by the Company to raise up to £10 million (with an over-allotment facility for up to a further £15 million) Healthcare Shares of 0.1p each following the approval of the Healthcare Prospectus by the Financial Conduct Authority.

 

The maximum number of shares that may be allotted under the Offers (including the over-allotment facility and shares to be allotted to management pursuant to performance incentive arrangements) is 40 million Healthcare Shares.

Smaller Related Party Transaction

Under the terms of the sponsor and promotion agreement (“Promotion Agreement”), the Company will pay the Healthcare Promoter, Downing LLP, a fee in relation to monies subscribed under the Offers (which could total up to £25 million if the over-allotment facility is fully utilised): of 3.0% where intermediary commission is payable or the application is direct, or 0% otherwise (“Promoter’s Fee”). In addition, a trail commission of 0.25% per annum of the Net Asset Value (“NAV”) of the Shares subscribed under the Offer will be payable to the Promoter, from which it will be responsible for paying trail commission to eligible intermediaries, with any excess reimbursed to the Company. Out of the Promoter’s Fee, the Promoter will be responsible for paying all the costs of the Offers.

Downing LLP, the Healthcare Promoter is also the investment manager to the Company in respect of the Healthcare Share pool and is a related party of the Company for the purposes of the Listing Rules. The fees referred to above constitute a smaller related party transaction for the purposes of the Listing Rules and, as such, Listing Rule 11.1.10 applies. The Board considers the fees to be in line with market practice.

 

The Offers will open for applications on at 1 pm on 26 October 2022 and will close at 12 noon on 5 April 2023 for the 2022/2023 tax year and 3.00 pm on 31 May 2023 for the 2023/2024 tax year, or earlier if the Offers are fully subscribed. The Board of the Company reserves the right to close the Offer earlier, or to extend the Offer (to no later than 30 September 2023).

 

The Healthcare Prospectus has been approved by the Financial Conduct Authority and will shortly be available to view at the online viewing facility of the National Storage Mechanism at the following website address: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Copies of the Healthcare Prospectus and are available, free of charge from the Company's registered office, St. Magnus House, 3 Lower Thames Street, London EC3R 6HD and on Downing's website at www.downing.co.uk/existing-investor/thames-ventures-vct-2

 

 

 

 

 

Date   Source Headline
28th Mar 20241:15 pmGNWCancellation of Listing of DSO D Shares and Cessation of Trading
15th Mar 202410:21 amGNWNet Asset Value(s)
29th Feb 20244:58 pmGNWDividend Declaration
21st Dec 20233:34 pmGNWHalf Yearly Results
18th Oct 20234:33 pmGNWSpecial administration of the Company’s custodian of quoted assets
13th Sep 20235:14 pmGNWNet Asset Values
13th Sep 20235:06 pmGNWCompany Secretary Change
13th Sep 20235:03 pmGNWResult of AGM
31st Jul 20233:57 pmGNWClosure of Offers for Subscription
31st Jul 20233:14 pmGNWFinal Results
31st May 20235:28 pmGNWTotal Voting Rights
30th May 20232:12 pmGNWOffer for Subscription Extension
12th May 20231:42 pmGNWIssue of Equity
2nd May 202310:49 amGNWTotal Voting Rights
5th Apr 20236:24 pmGNWIssue of Equity
31st Mar 20236:04 pmGNWTotal Voting Rights
31st Mar 20235:44 pmGNWTransaction in Own Shares
22nd Mar 20234:14 pmGNWNet Asset Values
31st Jan 20235:45 pmGNWTotal Voting Rights
17th Jan 20234:57 pmGNWTransaction in Own Shares & Total Voting Rights
22nd Dec 20225:08 pmGNWHalf-year report
13th Oct 20225:35 pmGNWPublication of Healthcare Prospectus
12th Oct 20224:40 pmGNWPortfolio Update and Net Asset Values
30th Sep 20225:27 pmGNWTotal Voting Rights
30th Sep 20225:25 pmGNWTransaction in Own Shares
28th Sep 20223:19 pmGNWDirectorate change
27th Sep 20225:56 pmGNWResult of AGM
7th Sep 202212:00 pmGNWChange of Name
1st Sep 202210:05 amGNWTotal Voting Rights
31st Aug 20224:59 pmGNWShare forfeiture and cancellation
3rd Aug 20225:12 pmGNWTransaction in Own Shares and Total Voting Rights
26th Jul 20227:00 amGNWNet Asset Value(s)
25th Jul 20226:28 pmGNWFinal Results
5th Jul 20227:00 amGNWCompletion of Sale of Downing non-healthcare ventures business to Foresight Group and Novation of Investment Management Agreement
30th Jun 20226:30 pmGNWTotal Voting Rights
13th Jun 20227:04 amGNWNovation of Investment Management Agreement
6th Jun 20224:34 pmGNWIssue of Equity
3rd May 202210:38 amGNWTotal Voting Rights
19th Apr 202211:29 amGNWIssue of Equity
6th Apr 202210:46 amGNWIssue of Equity
31st Mar 20225:46 pmGNWTotal Voting Rights
31st Mar 20225:35 pmGNWTransaction in Own Shares
30th Mar 20226:24 pmGNWIssue of Equity
4th Mar 20225:20 pmGNWTransaction in Own Shares
1st Mar 20225:35 pmGNWIssue of Equity
1st Mar 20229:09 amGNWTotal Voting Rights
28th Feb 202212:55 pmGNWNet Asset Value(s)
2nd Feb 20228:10 amGNWIssue of Equity
31st Jan 20225:09 pmGNWTotal Voting Rights
7th Jan 20222:54 pmGNWIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.